The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review
Abstract
DESCRIPTION Thanks to ready access to hydrogen breath testing, small intestinal bacterial overgrowth is now commonly diagnosed among individuals presenting with a variety of gastrointestinal and even non-gastrointestinal complaints and is increasingly implicated, in lay press and media in the causation of a diverse array of disorders. Its definition, however, remains controversial and true prevalence, accordingly, undefined. The purpose of this review, therefore, was to provide a historical background to the concept of SIBO, critically review current concepts of SIBO (including symptomatology, pathophysiology, clinical consequences, diagnosis and treatment), define unanswered questions and provide a road map towards their resolution. METHODS Best Practice Advice (BPA) statements were developed following discussion by the three authors. EMMQ and MP each developed text around certain BPAs based upon a review of available literature. A complete draft was reviewed by all three authors and following discussion, re-drafting and further review and revision a final draft was agreed upon by all authors. BEST PRACTICE ADVICE STATEMENTS The definition of SIBO as a clinical entity lacks precision and consistency; it is a term generally applied to a clinical disorder where symptoms, clinical signs and/or laboratory abnormalities are attributed to changes in the numbers of bacteria or in the composition of the bacterial population in the small intestine. Symptoms traditionally linked to SIBO include bloating, diarrhea and abdominal pain/discomfort. Steatorrhea may be seen in more severe cases. There is insufficient evidence to support the use of inflammatory markers such as fecal calprotectin to detect SIBO. Lab findings can include elevated folate and, less commonly, vitamin B12 deficiency, or other nutritional deficiencies. A major impediment to our ability to accurately define SIBO is our limited understanding of normal small intestinal microbial populations- progress in sampling technology and techniques to enumerate bacterial populations and their metabolic products should provide much needed clarity. Controversy remains concerning the role of SIBO in the pathogenesis of common functional symptoms such as those regarded as components of irritable bowel syndrome (IBS). Management should focus on the identification and correction (where possible) of underlying causes, correction of nutritional deficiencies and the administration of antibiotics. This is especially important for patients with significant maldigestion and malabsorption. While IBS has been shown to respond to therapy with a poorly absorbed antibiotic, the role of SIBO or its eradication in the genesis of this response warrants further confirmation in randomized controlled trials. There is a limited database to guide the clinician in developing antibiotic strategies for SIBO, in any context. Therapy remains, for the most part, empiric but must be ever mindful of the potential risks of long-term broad-spectrum antibiotic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036
Self-citationA Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth
Khoshini, R., Dai, S.-C., Lezcano, S., & Pimentel, M. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0065-1 · Cited by 323
Self-citationLembo, A., Pimentel, M., Rao, S. S., Schoenfeld, P., Cash, B., Weinstock, L. B., Paterson, C., Bortey, E., & Forbes, W. P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.003 · Cited by 310
Self-citation
Cited by
B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease
Lyon, P., Strippoli, V., Fang, B., & Cimmino, L. (2020) · Nutrients · doi:10.3390/nu12092867 · Cited by 437
Hammer, H. F., Fox, M. R., Keller, J., Salvatore, S., Basilisco, G., Hammer, J., Lopetuso, L., Benninga, M., Borrelli, O., Dumitrascu, D., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12133 · Cited by 189
Aetiology, diagnosis and management of small intestinal bacterial overgrowth
Ahmed, J. F., Padam, P., & Ruban, A. (2023) · Frontline Gastroenterology · doi:10.1136/flgastro-2022-102163 · Cited by 28
Diabetic gastroenteropathy: a pan-alimentary complication
Kornum, D. S., Krogh, K., Keller, J., Malagelada, C., Drewes, A. M., & Brock, C. (2025) · Diabetologia · doi:10.1007/s00125-025-06365-y · Cited by 23
Metadata
- Authors
- Quigley, E. M. M., Murray, J. A., & Pimentel, M.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 159
- Issue
- 4
- Pages
- 1526-1532
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W3042876334
- Cited by
- 220
- References
- 3
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review. https://app.cochat.ai/papers/10.1053/j.gastro.2020.06.090
- The paper
- Quigley, E. M. M., Murray, J. A., & Pimentel, M. (2020). AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.06.090
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.